EKR Therapeutics ekrtx.com


Public lists: Pharma Startups (4734)

EKR Therapeutics is a specialty pharmaceutical company committed to serving the acute-care hospital setting by identifying, commercializing, and marketing products to address unmet or undersatisfied medical needs. The company's product offerings include Ready-to-Use CARDENE I.V. (nicardipine hydrochloride), DepoDur (morphine sulfate extended-release liposome injection), and Retavase (reteplase, recombinant).

EKR Therapeutics is a specialty pharmaceutical company committed to serving the acute-care hospital setting by identifying, commercializing, and marketing products to address unmet or undersatisfied medical needs. The company's product offerings incl...Show all

Company (Acquired)

Phone: 877-435-2524

Fax:

1545 US Highway 206
Third Floor
Bedminster, 07921
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
EKR Therapeutics $160M May 16, 2012
Abaxis $14.1M May 16, 2018
Debiotech SA $0M Feb 20, 2019
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related EKR Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors

Competitors

Company Status Description Investors
See all 16 competitors